Latest filings (excl ownership)
ARS
2023 FY
Annual report to shareholders
26 Mar 24
DEFA14A
Additional proxy soliciting materials
26 Mar 24
DEF 14A
Definitive proxy
26 Mar 24
S-3
Shelf registration
25 Mar 24
10-K
2023 FY
Annual report
25 Mar 24
8-K
Material Modifications to Rights of Security Holders
12 Mar 24
PRE 14A
Preliminary proxy
11 Mar 24
8-K
Lexicon Pharmaceuticals Reports Fourth Quarter 2023
11 Mar 24
8-K
Entry into a Material Definitive Agreement
29 Dec 23
424B5
Prospectus supplement for primary offering
29 Dec 23
8-K
Entry into a Material Definitive Agreement
29 Dec 23
10-Q
2023 Q3
Quarterly report
8 Nov 23
8-K
Lexicon Pharmaceuticals Reports Third Quarter 2023
8 Nov 23
8-K
Departure of Directors or Certain Officers
11 Oct 23
S-8
Registration of securities for employees
4 Aug 23
10-Q
2023 Q2
Quarterly report
4 Aug 23
8-K
Lexicon Pharmaceuticals Reports Second Quarter 2023
3 Aug 23
8-K
Lexicon Elects Diane E. Sullivan to Board of Directors
31 Jul 23
8-K
Departure of Directors or Certain Officers
24 Jul 23
8-K
Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
28 Jun 23
D
$72.22 mm in equity, sold $72.22 mm, 1 investor
20 Jun 23
CT ORDER
Confidential treatment order
8 Jun 23
8-K
Lexicon Announces Pricing of $125 Million Public Offering and Concurrent Private Placement
2 Jun 23
424B5
Prospectus supplement for primary offering
1 Jun 23
FWP
Free writing prospectus
1 Jun 23
8-K
Lexicon Announces Proposed Public Offering of Common Stock
31 May 23
FWP
Free writing prospectus
31 May 23
424B5
Prospectus supplement for primary offering
31 May 23
8-K/A
Submission of Matters to a Vote of Security Holders
8 May 23
10-Q
2023 Q1
Quarterly report
4 May 23
8-K
Entry into a Material Definitive Agreement
2 May 23
8-K
Lexicon Pharmaceuticals Reports First Quarter 2023
2 May 23
8-K
Entry into a Material Definitive Agreement
27 Apr 23
DEFA14A
Additional proxy soliciting materials
17 Mar 23
DEF 14A
Definitive proxy
17 Mar 23
10-K
2019 FY
Annual report
3 Mar 23
8-K
Lexicon Pharmaceuticals Reports Fourth Quarter 2022
2 Mar 23
8-K
Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
4 Jan 23
10-Q
2022 Q3
Quarterly report
9 Nov 22
8-K
Lexicon Pharmaceuticals Reports Third Quarter 2022
9 Nov 22
Latest ownership filings
4
International S.C.A. Artal
13 Mar 24
SC 13D/A
Invus, L.P.
13 Mar 24
4
Kristen Alexander
29 Feb 24
4
JEFFREY L WADE
29 Feb 24
4
Wendy McDermott
29 Feb 24
4
ALAN J MAIN
29 Feb 24
4
Kenneth B. Kassler-Taub
29 Feb 24
4
Craig B Granowitz
29 Feb 24
4
Brian T Crum
29 Feb 24
4
LONNEL COATS
29 Feb 24
SC 13G/A
BIOTECHNOLOGY VALUE FUND L P
14 Feb 24
4
Kristen Alexander
12 Feb 24
4
JEFFREY L WADE
12 Feb 24
4
Wendy McDermott
12 Feb 24
4
ALAN J MAIN
12 Feb 24
4
Kenneth B. Kassler-Taub
12 Feb 24
4
Craig B Granowitz
12 Feb 24
4
Thomas Garner
12 Feb 24
4
Brian T Crum
12 Feb 24
4
LONNEL COATS
12 Feb 24
4
LONNEL COATS
17 Nov 23
4
Philippe Amouyal
14 Nov 23
4
LONNEL COATS
13 Nov 23
4
RAYMOND DEBBANE
12 Oct 23
4
Thomas Garner
11 Oct 23
3
Thomas Garner
11 Oct 23
4
JEFFREY L WADE
14 Sep 23
4
Wendy McDermott
7 Aug 23
4
Diane E. Sullivan
31 Jul 23
3
Diane E. Sullivan
31 Jul 23
144
Notice of proposed sale of securities
12 Jul 23
4
LONNEL COATS
29 Jun 23
4
Wendy McDermott
27 Jun 23
4
LONNEL COATS
26 Jun 23
4
LONNEL COATS
22 Jun 23
4
JEFFREY L WADE
20 Jun 23
SC 13D/A
Invus, L.P.
6 Jun 23
4
International S.C.A. Artal
5 Jun 23
4
Judith L Swain
22 May 23
4
CHRISTOPHER J SOBECKI
22 May 23